An Important History Lesson for Gene-Editing Investors
https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/?source=iedfolrf0000001
Dec 02, 2023 - Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.
0
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
https://www.fool.com/investing/2023/12/18/these-are-the-3-hottest-biopharma-trends-of-2024/?source=iedfolrf0000001
Dec 18, 2023 - 2024 is going to be a sizzler in the biopharma sector.
0
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/?source=iedfolrf0000001
Dec 21, 2023 - Which weight-loss stocks are good buys today?
0
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
https://www.fool.com/investing/2023/12/23/invivyd-stock-more-than-doubled-last-week-is/?source=iedfolrf0000001
Dec 23, 2023 - The clinical-stage biotech delivered positive trial results for its new COVID-19 preventative antibody treatment.
0
7 Incredible Reasons to Buy Pfizer Stock Right Now
https://www.fool.com/investing/2024/01/13/7-reasons-to-buy-pfizer-stock/?source=iedfolrf0000001
Jan 13, 2024 - The company's work should pay off eventually.
0
Pfizer (PFE) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/30/pfizer-pfe-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Jan 30, 2024 - PFE earnings call for the period ending December 31, 2023.
0
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
https://www.fool.com/investing/2024/02/17/is-it-too-late-to-buy-these-2-brilliant-passive-in/?source=iedfolrf0000001
Feb 17, 2024 - Patience will be rewarded with these stocks.
0
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?
https://www.fool.com/investing/2024/02/21/these-3-dividend-stocks-yield-more-than-5-but/?source=iedfolrf0000001
Feb 21, 2024 - Relying on payout ratio alone can sometimes give investors a misleading picture of just how safe a dividend payment is.
0
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
https://www.fool.com/investing/2023/12/02/why-im-considering-selling-pfizer-for-tax-loss-har/?source=iedfolrf0000001
Dec 02, 2023 - For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.
0
2 Big-Name Stocks Are Falling Wednesday -- Here's Why
https://www.fool.com/investing/2023/12/13/2-big-name-stocks-are-falling-wednesday-heres-why/?source=iedfolrf0000001
Dec 13, 2023 - Even as market participants wait for the latest from the Federal Reserve, some companies are having issues of their own.
0
Page 1>